Kotak Healthcare Fund
Holdings
34
Concentrated
Top 10 weight
57%
Concentration
Active share
90%
Highly Differentiated
Equity
99%
Asset allocation
Portfolio
4Sectors
4Large positions
71.2%Top: Pharmaceuticals and Biotechnology
0.0%Cash
Market-cap allocation
Large cap41%
Mid cap16%
Small cap41%
Asset allocation
Equity99%
Top holdings
14.9%
Divis Laboratories Ltd.EQUITY
8.3%6.2%
5.2%
Ami Organics LtdEQUITY
4.3%Cipla Ltd.EQUITY
4.3%3.9%
3.5%
MANKIND PHARMA LTDEQUITY
3.3%3.1%
3.0%
Gland Pharma LimitedEQUITY
2.8%Laurus Labs LtdEQUITY
2.7%2.6%
ANTHEM BIOSCIENCES LTDEQUITY
2.4%Ajanta Pharma Ltd.EQUITY
2.3%Marksans Pharma LtdEQUITY
2.3%RUBICON RESEARCH LIMITEDEQUITY
2.2%ORCHID PHARMA LIMITEDEQUITY
1.9%1.9%
CORONA REMEDIES LIMITEDEQUITY
1.9%JUBILANT INGREVIA LTD.EQUITY
1.8%Aurobindo Pharma Ltd.EQUITY
1.6%1.6%
Triparty RepoDERIVATIVE
1.5%Lupin Ltd.EQUITY
1.4%1.4%
1.3%
Zydus Lifesciences Ltd.EQUITY
1.2%DR.Lal Pathlabs LtdEQUITY
1.2%INNOVA CAPTABS LTDEQUITY
1.1%LAXMI DENTAL LIMITEDEQUITY
0.64%Net Current Assets/(Liabilities)DERIVATIVE
-0.3%AI Smart summary
Portfolio read
- 99% equity.
- 34 disclosed positions across 4 classified equity sectors.
- Largest equity sector is Pharmaceuticals and Biotechnology at 71.2% of the portfolio.
Watchpoints
- Small-cap exposure is 41%, which may increase volatility and liquidity risk.
- Sector concentration is elevated: Pharmaceuticals and Biotechnology represents 71%.
Auto-generated from fund metrics. Educational only - not investment advice.
Peer comparison
Other funds in Sectoral / Thematic.
HDFC Manufacturing fund91 holdings · 34% top 10 · 80% AS
UTI Quant Fund89 holdings · 36% top 10
Icici Prudential Energy Opportunities Fund88 holdings · 43% top 10 · 83% AS
ICICI Prudential Business Cycle Fund86 holdings · 50% top 10 · 70% AS
Edelweiss Technology Fund84 holdings · 54% top 10
Axis Business Cycles Fund81 holdings · 29% top 10 · 67% AS
Sector exposure
Full industry / sector breakdown aggregated from the fund's holdings.
71.2%
25.1%
1.8%
0.6%